English
简体中文
Total: £ 56.28
Published Date: 2025-09-05 | Pages: 75 | Tables: 73 | Medical Care
The global market for Hospital-acquired Urinary Tract Infection Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-acquired Urinary Tract Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-acquired Urinary Tract Infection Testing.
The Hospital-acquired Urinary Tract Infection Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hospital-acquired Urinary Tract Infection Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-acquired Urinary Tract Infection Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
bioMérieux
Roche Diagnostics
Siemens Healthineer
ACON Laboratories
Abbott
ARKRAY
Beckman Coulter
Becton Dickinson
Bio-Rad
Cepheid
Segment by Type
Assay kits and consumables
Instruments
Segment by Application
Hospitals and outpatient department
Diagnostics clinical laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-acquired Urinary Tract Infection Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assay kits and consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Hospital-acquired Urinary Tract Infection Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and outpatient department
1.3.3 Diagnostics clinical laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Perspective (2020-2031)
2.2 Global Hospital-acquired Urinary Tract Infection Testing Growth Trends by Region
2.2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hospital-acquired Urinary Tract Infection Testing Historic Market Size by Region (2020-2025)
2.2.3 Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Region (2026-2031)
2.3 Hospital-acquired Urinary Tract Infection Testing Market Dynamics
2.3.1 Hospital-acquired Urinary Tract Infection Testing Industry Trends
2.3.2 Hospital-acquired Urinary Tract Infection Testing Market Drivers
2.3.3 Hospital-acquired Urinary Tract Infection Testing Market Challenges
2.3.4 Hospital-acquired Urinary Tract Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-acquired Urinary Tract Infection Testing Players by Revenue
3.1.1 Global Top Hospital-acquired Urinary Tract Infection Testing Players by Revenue (2020-2025)
3.1.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Players (2020-2025)
3.2 Global Hospital-acquired Urinary Tract Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hospital-acquired Urinary Tract Infection Testing Revenue
3.4 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio
3.4.1 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Urinary Tract Infection Testing Revenue in 2024
3.5 Global Key Players of Hospital-acquired Urinary Tract Infection Testing Head office and Area Served
3.6 Global Key Players of Hospital-acquired Urinary Tract Infection Testing, Product and Application
3.7 Global Key Players of Hospital-acquired Urinary Tract Infection Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired Urinary Tract Infection Testing Breakdown Data by Type
4.1 Global Hospital-acquired Urinary Tract Infection Testing Historic Market Size by Type (2020-2025)
4.2 Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Type (2026-2031)
5 Hospital-acquired Urinary Tract Infection Testing Breakdown Data by Application
5.1 Global Hospital-acquired Urinary Tract Infection Testing Historic Market Size by Application (2020-2025)
5.2 Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hospital-acquired Urinary Tract Infection Testing Market Size (2020-2031)
6.2 North America Hospital-acquired Urinary Tract Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025)
6.4 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-acquired Urinary Tract Infection Testing Market Size (2020-2031)
7.2 Europe Hospital-acquired Urinary Tract Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025)
7.4 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size (2020-2031)
8.2 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-acquired Urinary Tract Infection Testing Market Size (2020-2031)
9.2 Latin America Hospital-acquired Urinary Tract Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025)
9.4 Latin America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size (2020-2031)
10.2 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 bioMérieux
11.1.1 bioMérieux Company Details
11.1.2 bioMérieux Business Overview
11.1.3 bioMérieux Hospital-acquired Urinary Tract Infection Testing Introduction
11.1.4 bioMérieux Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.1.5 bioMérieux Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Introduction
11.2.4 Roche Diagnostics Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.2.5 Roche Diagnostics Recent Development
11.3 Siemens Healthineer
11.3.1 Siemens Healthineer Company Details
11.3.2 Siemens Healthineer Business Overview
11.3.3 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Introduction
11.3.4 Siemens Healthineer Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.3.5 Siemens Healthineer Recent Development
11.4 ACON Laboratories
11.4.1 ACON Laboratories Company Details
11.4.2 ACON Laboratories Business Overview
11.4.3 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Introduction
11.4.4 ACON Laboratories Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.4.5 ACON Laboratories Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Hospital-acquired Urinary Tract Infection Testing Introduction
11.5.4 Abbott Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 ARKRAY
11.6.1 ARKRAY Company Details
11.6.2 ARKRAY Business Overview
11.6.3 ARKRAY Hospital-acquired Urinary Tract Infection Testing Introduction
11.6.4 ARKRAY Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.6.5 ARKRAY Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Introduction
11.7.4 Beckman Coulter Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.7.5 Beckman Coulter Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Details
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Introduction
11.8.4 Becton Dickinson Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.8.5 Becton Dickinson Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Introduction
11.9.4 Bio-Rad Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Hospital-acquired Urinary Tract Infection Testing Introduction
11.10.4 Cepheid Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
11.10.5 Cepheid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assay kits and consumables
Table 3. Key Players of Instruments
Table 4. Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Hospital-acquired Urinary Tract Infection Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hospital-acquired Urinary Tract Infection Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Region (2020-2025)
Table 8. Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Region (2026-2031)
Table 10. Hospital-acquired Urinary Tract Infection Testing Market Trends
Table 11. Hospital-acquired Urinary Tract Infection Testing Market Drivers
Table 12. Hospital-acquired Urinary Tract Infection Testing Market Challenges
Table 13. Hospital-acquired Urinary Tract Infection Testing Market Restraints
Table 14. Global Hospital-acquired Urinary Tract Infection Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Players (2020-2025)
Table 16. Global Top Hospital-acquired Urinary Tract Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Urinary Tract Infection Testing as of 2024)
Table 17. Ranking of Global Top Hospital-acquired Urinary Tract Infection Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Hospital-acquired Urinary Tract Infection Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Hospital-acquired Urinary Tract Infection Testing, Headquarters and Area Served
Table 20. Global Key Players of Hospital-acquired Urinary Tract Infection Testing, Product and Application
Table 21. Global Key Players of Hospital-acquired Urinary Tract Infection Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. bioMérieux Company Details
Table 47. bioMérieux Business Overview
Table 48. bioMérieux Hospital-acquired Urinary Tract Infection Testing Product
Table 49. bioMérieux Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 50. bioMérieux Recent Development
Table 51. Roche Diagnostics Company Details
Table 52. Roche Diagnostics Business Overview
Table 53. Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Product
Table 54. Roche Diagnostics Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 55. Roche Diagnostics Recent Development
Table 56. Siemens Healthineer Company Details
Table 57. Siemens Healthineer Business Overview
Table 58. Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Product
Table 59. Siemens Healthineer Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineer Recent Development
Table 61. ACON Laboratories Company Details
Table 62. ACON Laboratories Business Overview
Table 63. ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Product
Table 64. ACON Laboratories Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 65. ACON Laboratories Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Hospital-acquired Urinary Tract Infection Testing Product
Table 69. Abbott Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. ARKRAY Company Details
Table 72. ARKRAY Business Overview
Table 73. ARKRAY Hospital-acquired Urinary Tract Infection Testing Product
Table 74. ARKRAY Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 75. ARKRAY Recent Development
Table 76. Beckman Coulter Company Details
Table 77. Beckman Coulter Business Overview
Table 78. Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Product
Table 79. Beckman Coulter Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 80. Beckman Coulter Recent Development
Table 81. Becton Dickinson Company Details
Table 82. Becton Dickinson Business Overview
Table 83. Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Product
Table 84. Becton Dickinson Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 85. Becton Dickinson Recent Development
Table 86. Bio-Rad Company Details
Table 87. Bio-Rad Business Overview
Table 88. Bio-Rad Hospital-acquired Urinary Tract Infection Testing Product
Table 89. Bio-Rad Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 90. Bio-Rad Recent Development
Table 91. Cepheid Company Details
Table 92. Cepheid Business Overview
Table 93. Cepheid Hospital-acquired Urinary Tract Infection Testing Product
Table 94. Cepheid Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025) & (US$ Million)
Table 95. Cepheid Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Hospital-acquired Urinary Tract Infection Testing Picture
Figure 2. Global Hospital-acquired Urinary Tract Infection Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Type: 2024 VS 2031
Figure 4. Assay kits and consumables Features
Figure 5. Instruments Features
Figure 6. Global Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and outpatient department Case Studies
Figure 9. Diagnostics clinical laboratories Case Studies
Figure 10. Hospital-acquired Urinary Tract Infection Testing Report Years Considered
Figure 11. Global Hospital-acquired Urinary Tract Infection Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Hospital-acquired Urinary Tract Infection Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Region: 2024 VS 2031
Figure 14. Global Hospital-acquired Urinary Tract Infection Testing Market Share by Players in 2024
Figure 15. Global Top Hospital-acquired Urinary Tract Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired Urinary Tract Infection Testing as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Hospital-acquired Urinary Tract Infection Testing Revenue in 2024
Figure 17. North America Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Hospital-acquired Urinary Tract Infection Testing Market Share by Country (2020-2031)
Figure 19. United States Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Hospital-acquired Urinary Tract Infection Testing Market Share by Country (2020-2031)
Figure 23. Germany Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Share by Region (2020-2031)
Figure 31. China Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Hospital-acquired Urinary Tract Infection Testing Market Share by Country (2020-2031)
Figure 39. Mexico Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Share by Country (2020-2031)
Figure 43. Turkey Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Hospital-acquired Urinary Tract Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. bioMérieux Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 47. Roche Diagnostics Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 48. Siemens Healthineer Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 49. ACON Laboratories Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 51. ARKRAY Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 52. Beckman Coulter Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 53. Becton Dickinson Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 54. Bio-Rad Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 55. Cepheid Revenue Growth Rate in Hospital-acquired Urinary Tract Infection Testing Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
